Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
The price of Greenwich LifeSciences Inc (NASDAQ: GLSI) closed at $25.47 in the last session, up 8.11% from day before closing price of $23.56. In other words, the price has increased by $8.11 from its previous closing price. On the day, 0.57 million shares were traded. GLSI stock price reached its highest trading level at $26.9292 during the session, while it also had its lowest trading level at $22.65.
Ratios:
We take a closer look at GLSI’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 2.35 and its Current Ratio is at 2.35. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In the most recent recommendation for this company, Noble Capital Markets on August 20, 2025, initiated with a Outperform rating and assigned the stock a target price of $45.
On September 01, 2021, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $78.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jan 13 ’26 when Patel Snehal bought 1,800 shares for $29.83 per share. The transaction valued at 53,694 led to the insider holds 5,604,102 shares of the business.
Patel Snehal bought 2,900 shares of GLSI for $79,866 on Jan 12 ’26. The CEO and CFO now owns 5,602,302 shares after completing the transaction at $27.54 per share. On Dec 31 ’25, another insider, Patel Snehal, who serves as the CEO and CFO of the company, bought 4,300 shares for $21.36 each. As a result, the insider paid 91,848 and bolstered with 5,599,402 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GLSI now has a Market Capitalization of 352875104 and an Enterprise Value of 349068128.
Stock Price History:
The Beta on a monthly basis for GLSI is 1.45, which has changed by 0.91792166 over the last 52 weeks, in comparison to a change of 0.15024745 over the same period for the S&P500. Over the past 52 weeks, GLSI has reached a high of $32.91, while it has fallen to a 52-week low of $7.78. The 50-Day Moving Average of the stock is 68.53%, while the 200-Day Moving Average is calculated to be 121.18%.
Shares Statistics:
According to the various share statistics, GLSI traded on average about 463.98K shares per day over the past 3-months and 1046180 shares per day over the past 10 days. A total of 13.79M shares are outstanding, with a floating share count of 6.57M. Insiders hold about 52.61% of the company’s shares, while institutions hold 9.61% stake in the company. Shares short for GLSI as of 1767139200 were 1669533 with a Short Ratio of 3.60, compared to 1764288000 on 1610157. Therefore, it implies a Short% of Shares Outstanding of 1669533 and a Short% of Float of 24.33.
Earnings Estimates
The market rating for Greenwich LifeSciences Inc (GLSI) is a result of the insights provided by 2.0 analysts actively involved in the assessment.The consensus estimate for the next quarter is -$0.33, with high estimates of -$0.31 and low estimates of -$0.35.
Analysts are recommending an EPS of between -$1.15 and -$1.3 for the fiscal current year, implying an average EPS of -$1.23. EPS for the following year is -$1.36, with 2.0 analysts recommending between -$1.24 and -$1.48.
